Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Perrigo (PRGO +1.6%) files an Abbreviated New Drug Application with the FDA for albuterol...

  • Thursday, September 6, 2012, 1:36 PM ET
    Perrigo (PRGO +1.6%) files an Abbreviated New Drug Application with the FDA for albuterol sulfate HFA inhalation aerosol, a generic version of Teva Pharmaceutical's (TEVA +1%) ProAir HFA. The filing involves contributions from both PRGO and Catalent Pharma Solutions, who partnered on the development. TEVA claims the application violates its patent on the drug, and yesterday it filed suit against both companies in U.S. District Court alleging patent infringement.
Track new comments on this story

This news story has 1 comment:

  •  
    I will wait the results from U.S. District Court.
    6 Sep 2012, 02:40 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »